Fate Therapeutics, Inc. (FATE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for FATE. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 149 institutions reported holding FATE, with 71.5 million shares worth $193.1 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Redmile Group | 12,872,946 | $35M | UNCHANGED |
| Vanguard | 9,773,984 | $26M | INCREASED |
| BlackRock | 7,298,895 | $20M | DECREASED |
| Acadian Asset Management | 4,351,250 | $12M | INCREASED |
| AQR Capital Management | 3,837,229 | $10M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Fate Therapeutics, Inc. on SentiSense.